Sort
130,381 grants matching “hiv”
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS
$776,215Janna Zumbrun · Texas State Department Of Health Srvs · U62 · FY2011 · PS
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$776,214Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2020 · AI
Improving Diagnosis, Treatment & Detection of Drug Resistance in HIV-2 Infection
$776,203Geoffrey Scott Gottlieb · University Of Washington · R01 · FY2015 · AI
An HIV Prevention Program for Mochudi, Botswana
$776,183Myron E Essex · Harvard School Of Public Health · R01 · FY2012 · AI
Application of a syndemic framework to HPV and HSV infection in emergent adult men
$776,149Danielle C Ompad · New York University · R01 · FY2018 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$776,131Otto O Yang · University Of California Los Angeles · R01 · FY2024 · AI
Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy
$776,106Vincent Lo Re · University Of Pennsylvania · R01 · FY2022 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$776,096Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Immunoevasive Mucosal Vaccines Against HIV-1
$776,040Michael A Barry · Mayo Clinic Rochester · R01 · FY2015 · AI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors
$776,021Research Inst Nationwide Children'S Hosp · P01 · FY2003 · AI
Next generation ultra-long acting antiretroviral formulations for HIV treatment and prevention
$776,006J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Next generation ultra-long acting antiretroviral formulations for HIV treatment and prevention
$776,006J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Next generation ultra-long acting antiretroviral formulations for HIV treatment and prevention
$776,006J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Cannabinoid modulation of EV composition and function in HIV/SIV infection
$775,988Chioma M Okeoma · New York Medical College · R01 · FY2022 · DA
Tethering lentiviral restriction to Fc-mediated antibody responses
$775,982David T Evans · University Of Wisconsin-Madison · R01 · FY2023 · AI
Humoral Correlates of Protection Against HIV
$775,917Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2016 · AI
A Multilevel Comprehensive Response on Uptake and Adherence to HIV Prevention Among Adolescent Girls and Young Women
$775,898Wendee M Wechsberg · Research Triangle Institute · R01 · FY2020 · HD
Efficacy of Internet-based HIV prevention
$775,843Brian Mustanski · Northwestern University At Chicago · R01 · FY2014 · DA
Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial
$775,833Naresh Punjabi · Johns Hopkins University · R01 · FY2016 · HL
A Rhesus Macaque Model of HIV and HBV co-infection
$775,817Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2022 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$775,815Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B
$775,800Michael J Lenardo · Niaid Extramural Activities · Z01 · FY2007 · AI
Risk, Roles and Relationships: Project Prepared
$775,790Laurie J Bauman · Albert Einstein College Of Medicine · R01 · FY2010 · HD
EPIDEMIOLOGY OF NEWLY DIAGNOSED PSYCHOTIC DISORDERS
$775,769State University New York Stony Brook · R01 · FY2001 · MH
HIV cure studies: risk, risk perception, and ethics
$775,766Nir Eyal · Harvard School Of Public Health · R01 · FY2017 · AI